Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 29927-08-0 | MDL No. : | MFCD00005790 |
Formula : | C9H10N2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IODWHFFPQHUDAG-UHFFFAOYSA-N |
M.W : | 178.25 | Pubchem ID : | 34757 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 53.96 |
TPSA : | 67.15 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.43 cm/s |
Log Po/w (iLOGP) : | 2.01 |
Log Po/w (XLOGP3) : | 2.76 |
Log Po/w (WLOGP) : | 2.5 |
Log Po/w (MLOGP) : | 1.9 |
Log Po/w (SILICOS-IT) : | 3.31 |
Consensus Log Po/w : | 2.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.24 |
Solubility : | 0.103 mg/ml ; 0.000577 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.83 |
Solubility : | 0.0266 mg/ml ; 0.000149 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.38 |
Solubility : | 0.0738 mg/ml ; 0.000414 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.13 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7% | In 1,2-dimethoxyethane; at 85℃; | Example 66 Ethyl 10,ll-dimethyl-7-thia-2,5-diazatricyclo[6.4.0.02,6]dodeca-l(8),3,5,9,ll- pentaene-4-carboxylate To a stirred solution of 5,6-dimethyl-l ,3-benzothiazol-2-amine (1.00 g, 5.61 mmol) in DME (13 mL) was added ethyl 3-bromo-2-oxopropanoate (1.93 g, 8.41 mmol) and the solution heated at 85C overnight. The reaction was poured onto ice/water (10 mL) and basified with N (aq). The resulting precipitate was collected by filtration and purified by FCC (eluent: 30% EtOAc in heptane), affording the title compound as a white solid (112 mg, 7% yield); 1H NMR (500 MHz, Chloroform-d) delta 1.45 (t, 3H), 2.40 (s, 3H), 2.43 (s, 3H), 4.45 (q, 2H), 7.46 (s, IH), 7.48 (s, IH), 8.32 (s, IH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; sodium nitrite;copper(I) chloride; In hydrogenchloride; chloroform; sulfuric acid; acetic acid; | (i) A slurry of 2-amino-5,6-dimethylbenzthiazole (3.33 g) in glacial acetic acid (35 ml) was added slowly to a cooled (below 20 C.) solution of sodium nitrite in concentrated sulphuric acid (20 ml) with constant stirring. The reaction mixture was stirred for 1/2 hour, whilst the temperature was maintained below 20 C. Ether (300 ml) was added slowly and the resultant mixture was stirred at 0 C. for one hour. A precipitate was collected which was added directly to a cold solution of cuprous chloride (1.85 g) in hydrochloric acid (5N, 70 ml). The mixture was neutralised by the addition of potassium carbonate and a resultant brown precipitate was collected. This was subjected to column chromatography on silica using chloroform as eluant to give 2-chloro-5,6-dimethylbenzthiazole (273 mg), m.p. 175 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | EXAMPLE 19 N-(5,6-Dimethyl-2-benzothiazolyl)-4-hydroxy-2-methyl-2H-[1] benzothieno [2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide Prepared analogous to Example 1 from benzyl 4-hydroxy-2-methyl-2H-[1] benzothieno [2,3-e]-1,2-thiazine-3-carboxylate-1,1-dioxide and 5,6-dimethyl-2-benzothiazolamine with a yield of 80% of theory. M.p.: 267-268 C. (decomp.) after recrystallization from dimethylformamide. C21 H17 N3 O4 S3 (471.58): Calc.: C-53.49%; H-3.63%; N-8.91%; S-20.40%; Found: C-53.20%; H-3.66%; N-9.18%; S-20.30% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium hydroxide; PPA; sodium borohydrid; triethylamine; In dichloromethane; water; | EXAMPLE 26 6,7-Dimethylthieno[3,4-b][1,5]benzothiazepin-10(9H)-one A solution of 44.5 g. of <strong>[29927-08-0]2-amino-5,6-dimethylbenzothiazole</strong> and 160 g. of potassium hydroxide in 320 ml of water was refluxed 16 hr and filtered. The filtrate was neutralized with 50% aqueous acetic acid and cooled to 10. The precipitate was collected by filtration and recrystallized from methanol:water to give 6,6'-(dithio)di-3,4-xylidene as yellow crystals, m.p. 139-140 C. A 164 g. portion of the above product in 100 ml of methylene chloride containing 11.1 g. of triethylamine was treated with 20.54 g. of 4-ethoxy-3-thiophenecarbonyl chloride in methylene chloride as in Example 14. The crude product is recrystallized from methylene chloride:petroleum ether to give 6',6"'-(dithio)bis[4-ethoxy-3-thiophene-3',4'-xylidide]-as yellow crystals, m.p. 206-208 C. A 12.2 g. portion of the above product was treated with 1.90 g. of sodium borohydride as in Example 25. The mixture was cooled to 0, filtered and the filtrate was concentrated in vacuo to give a yellow oil. The yellow oil was treated with 75 g. of polyphosphoric acid as described in Example 1 to give 6,7-dimethylthieno[3,4-b][1,5]benzothiazepin-10(9H)-one as white crystals, m.p. 264-265 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; | General procedure: To a solution of 2-aminobenzothiazole (150 mg, 1 mmol) in dichloromethane (20 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) (210 mg, 1.1 mmol) and 1-hydroxy-1,2,3-benzotriazole (HOBt) (13.5 mg, 0.1 mmol). Then compound 8 (402 mg, 1 mmol) was added and the reaction mixture was stirred at room temperature for 14 h and the reaction was monitored by TLC. After completion of reaction, water was added to reaction mixture and extracted with dichloromethane (2 × 30 ml). The organic layer was dried with Na2SO4 and evaporated under vacuum to afford the crude product. This was further purified by column chromatography using ethyl acetate and hexane (1:1) as solvent system to obtain the pure product 9a as yellow solid. (449 mg, 84% yield); |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: In a 100 mL two neck round bottom flask, of which one neck is fitted with a reflux condenser, the mixture of 0.01 mol of substituted 2-aminobenzothiazole (2, a-d), 0.02 mol sodium hydride under N2 atmosphere in 5-10 mL of dry THF was added through the other neck, and the reaction mixture was stirred at room temperature for 10-15 min. Into the reaction mixture 0.01 mol 1-aryl-3,3-bis-(methylsulfanyl)-2-propen-1-ones (1, a-f) i.e. aroyl ketene dithioacetal in 10 mL dry THF was added and the mixture was refluxed. Progress of the reaction was monitored by TLC (hexane: EtOAc, 8:2). After completion of the reaction, the reaction mixture was poured into crushed ice (250 mL of ice-water) with vigorous stirring and then stirred at room temperature for another 30 min. The reddish or yellow precipitate formed was filtered, washed with cold water and dried. The crude product was recrystalized from MeOH or CHCl3: MeOH. The recrystalized product was characterized by various spectroscopic techniques. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 20℃; for 8.16667h; | General procedure: to a solution of compounds (10a-d) (0.6 mmol) in dichloromethane (20 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) (1.2 mmol) and 1-hydroxy-1,2,3-benzotriazole (HOBt) (0.1 mmol). Then added corresponding 2-aminobenzothiazoles 11a-e (0.6 mmol) at 0 C. After 10 min, the reaction mixture was stirred at room temperature for 8 h. The reaction was monitored by TLC. After completion of reaction, water was added to reaction mixture and the aqueous phase was extracted with dichloromethane (2 × 30 ml). The organic layer was dried with Na2SO4 and evaporated under reduced pressure to afford the crude product which was further purified by column chromatography on silica gel using ethyl acetate and hexane as solvent system to obtain the pure products as yellow solids. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 20℃; for 8.16667h; | General procedure: to a solution of compounds (10a-d) (0.6 mmol) in dichloromethane (20 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) (1.2 mmol) and 1-hydroxy-1,2,3-benzotriazole (HOBt) (0.1 mmol). Then added corresponding 2-aminobenzothiazoles 11a-e (0.6 mmol) at 0 C. After 10 min, the reaction mixture was stirred at room temperature for 8 h. The reaction was monitored by TLC. After completion of reaction, water was added to reaction mixture and the aqueous phase was extracted with dichloromethane (2 × 30 ml). The organic layer was dried with Na2SO4 and evaporated under reduced pressure to afford the crude product which was further purified by column chromatography on silica gel using ethyl acetate and hexane as solvent system to obtain the pure products as yellow solids. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 20℃; for 8.16667h; | General procedure: to a solution of compounds (10a-d) (0.6 mmol) in dichloromethane (20 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) (1.2 mmol) and 1-hydroxy-1,2,3-benzotriazole (HOBt) (0.1 mmol). Then added corresponding 2-aminobenzothiazoles 11a-e (0.6 mmol) at 0 C. After 10 min, the reaction mixture was stirred at room temperature for 8 h. The reaction was monitored by TLC. After completion of reaction, water was added to reaction mixture and the aqueous phase was extracted with dichloromethane (2 × 30 ml). The organic layer was dried with Na2SO4 and evaporated under reduced pressure to afford the crude product which was further purified by column chromatography on silica gel using ethyl acetate and hexane as solvent system to obtain the pure products as yellow solids. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 20℃; for 8.16667h; | General procedure: to a solution of compounds (10a-d) (0.6 mmol) in dichloromethane (20 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) (1.2 mmol) and 1-hydroxy-1,2,3-benzotriazole (HOBt) (0.1 mmol). Then added corresponding 2-aminobenzothiazoles 11a-e (0.6 mmol) at 0 C. After 10 min, the reaction mixture was stirred at room temperature for 8 h. The reaction was monitored by TLC. After completion of reaction, water was added to reaction mixture and the aqueous phase was extracted with dichloromethane (2 × 30 ml). The organic layer was dried with Na2SO4 and evaporated under reduced pressure to afford the crude product which was further purified by column chromatography on silica gel using ethyl acetate and hexane as solvent system to obtain the pure products as yellow solids. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | General procedure: 2-Aminobenzothiazole (0.30 g, 2.0 mmol) was dissolved in hot glacial acetic acid/propionic acid mixture (2:1, 6.0 ml) and was rapidly cooled in an ice-salt bath to -5 C. The mixture was then stirred for 2 h. at 0-5 C. The liquor was then added in portions during 30 min to a cold solution of nitrosyl sulfuric acid [prepared from sodium nitrite (0.15 g) and concentrated sulfuric acid (3 ml at 50 C)]. The mixture was stirred for an additional 2 h at 0 C. Excess nitrous acid was destroyed by the addition of urea. The resulting diazonium salt was cooled in salt/ice mixture. 2-methlyindole(0.26 g, 2.0 mmol) was dissolved in mixture of acetic acid/propionic acid solution (3:1, 8.0 ml) and cooled in salt/ice bath and then cold diazonium solution was added to this cooled solution by stirring in a dropwise manner. The solution was stirred at 0-5 C for 2 h. and pH of the reaction mixture was maintained at 4-6 by simultaneous addition of saturated sodium carbonate solution.The mixture was stirred for a further 1 h at 5 C. The resulting product was filtered, washed with water, dried and crystallized from ethanol mixture gave brown powder (yield: 0.29 g, 51%; m.p: 168-170 C), FT-IR (KBr) numax: 3345 (indole -NH), 3059 (aromatic C-H), 2969, 2920 (aliphatic C-H), 1605 (C=C) cm-1; 1HNMR (DMSO-d6/CDCl3): d 9.71 (b, indole -NH), 7.98 (1H,m), 7.37(1H,m), 7.30-7.15 (4H,m), 6.82 (2H,m), 2.36 (3H,s).Anal. Calcd. For C16H12N4S: C, 65.73; H, 4.14; N, 19.16; S, 10.97Found: C, 65.68; H, 4.19; N, 19.11; S, 10.92%.MS (m/z, 70 eV): 292.0 (M+), 277.0, 158.0, 130.0. |
Tags: 29927-08-0 synthesis path| 29927-08-0 SDS| 29927-08-0 COA| 29927-08-0 purity| 29927-08-0 application| 29927-08-0 NMR| 29927-08-0 COA| 29927-08-0 structure
[ 19759-66-1 ]
2-Aminobenzothiazole-6-carbonitrile
Similarity: 0.91
[ 78584-08-4 ]
4,7-Dimethylbenzo[d]thiazol-2-amine
Similarity: 0.87
[ 21224-16-8 ]
6-Ethyl-1,3-benzothiazol-2-amine
Similarity: 0.85
[ 14779-18-1 ]
7-Methylbenzo[d]thiazol-2-amine
Similarity: 0.84
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :